Literature DB >> 3012832

Passive transfer of cytomegalovirus by cardiac and renal organ transplants in a rat model.

J H Bruning, C A Bruggeman, C P van Boven, P J van Breda Vriesman.   

Abstract

Passive transfer of latent rat cytomegalovirus (R-CMV) infection by means of vascularized organ transplants was examined in inbred rat strains. LEWIS (LEW) rats 4-5 weeks old were infected with RCMV and used as donors at 5 months of age when the infection had become latent. Well-perfused LEW hearts and kidneys were transplanted into unmodified or 500-rad x-irradiated syngeneic or allogeneic Brown Norway (BN) recipients; recipients were sacrificed 3 weeks after transplantation, and RCMV virus from various organs was quantitated by means of a plaque assay. Passive transfer of latent infection could be accomplished with renal allografts (60%) and renal isografts (40%). When BN hosts were x-irradiated LEW renal allografts invariably transferred the latent infection (100%); cardiac allografts rarely did so (8%). X-irradiation of syngeneic hosts did not enhance the capacity of LEW kidneys to transfer the latent infection. The latent infection could not be transferred with thoracic duct lymphocytes. Results show the passive transfer of latent infection with well-perfused vascularized organ allografts to be a relative organ-specific phenomenon.

Entities:  

Mesh:

Year:  1986        PMID: 3012832     DOI: 10.1097/00007890-198606000-00005

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  6 in total

1.  Treatment of experimental cytomegalovirus infections with acyclovir.

Authors:  C A Bruggeman; W Engels; J Endert
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

2.  The development and characterization of monoclonal antibodies against rat cytomegalovirus induced antigens.

Authors:  J H Bruning; W H Debie; P H Dormans; H Meijer; C A Bruggeman
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

3.  Allogeneic transplantation induces expression of cytomegalovirus immediate-early genes in vivo: a model for reactivation from latency.

Authors:  M Hummel; Z Zhang; S Yan; I DePlaen; P Golia; T Varghese; G Thomas; M I Abecassis
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

4.  An animal model for therapeutic intervention studies of CMV infection in the immunocompromised host.

Authors:  F S Stals; F Bosman; C P van Boven; C A Bruggeman
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

5.  Inflammatory cells in transplanted kidneys are infected by human cytomegalovirus.

Authors:  J W Gnann; J Ahlmén; C Svalander; L Olding; M B Oldstone; J A Nelson
Journal:  Am J Pathol       Date:  1988-08       Impact factor: 4.307

6.  Rat cytomegalovirus-induced pneumonitis after allogeneic bone marrow transplantation: effective treatment with (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine.

Authors:  F S Stals; A Zeytinoglu; M Havenith; E de Clercq; C A Bruggeman
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.